Replimune Group, Inc. Ratios

Ratios Mar2020 Mar2021 Mar2022 Mar2023 Mar2024 Mar2025
Profitability
EBT Margin 7,426.16%9,762.47%8,863.78%4,789.55%4,274.10%
EBIT Margin 7,656.40%9,774.45%9,020.89%5,220.66%4,530.34%
EBITDA Margin 7,656.40%9,774.45%9,020.89%5,220.66%4,530.34%
Operating Margin 7,656.40%9,774.45%9,020.89%5,220.66%4,530.34%
Net Margin 7,169.62%9,886.31%8,878.45%4,798.62%4,282.20%
FCF Margin 9,140.60%7,797.19%6,638.82%4,250.14%3,444.80%
Leverage & Solvency
Interest Coverage Ratio -76.56-97.74-90.21-52.21-45.30
Times Interest Earned -76.56-97.74-90.21-52.21-45.30
Valuation
Enterprise Value 365.36M1,418.52M801.62M1,000.53M501.54M750.89M
Market Capitalization 365.36M1,418.52M801.62M1,000.53M501.54M750.89M
Return Ratios
Return on Sales 74.26%97.62%88.79%47.99%42.83%